Stoke Therapeutics Presents Data Related to the Ongoing Clinical Development of STK-001 for the Treatment of Dravet Syndrome at the 35th International Epilepsy Congress
DUBLIN--(BUSINESS WIRE)--Sep 5, 2023--
Source: eagletribune.com
📰 Digital Poster Presentation News
Digital Poster Presentation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Digital Poster Presentation. Real-time updates on events, politics, business and more.
Stoke Therapeutics Presents Data Related to the Ongoing Clinical Development of STK-001 for the Trea
– Data from multiple ongoing clinical studies of STK-001 show reductions in convulsive seizure frequency and improvements in cognition and behavior in children and adolescents with Dravet syndrome –– Data support the potential for STK-001 to be the first disease-modifying treatment for Dravet syndrome –– New pharmac...
Source: pharmiweb.com
Radix at TAPPICon 2023: Demonstrating How Data Can Maximize Value Creation for Manufacturers
Radix at TAPPICon 2023: Demonstrating How Data Can Maximize Value Creation for Manufacturers
Source: whattheythink.com
Radix at TAPPICon 2023: Demonstrating How Data Can Maximize
HOUSTON, April 11, 2023 (GLOBE NEWSWIRE) -- Radix Engineering will be a Ruby sponsor, exhibitor, and presenter at TAPPICon 2023, April 22-26, 2023,...
Source: globenewswire.com